Jakko van Ingen

63PUBLICATIONS

88CO-AUTHORS

Medical bacteriologyMedical mycologyNanotoxicology, health and safetyComputational physiologyNanomedicine

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (63)

Sort by Publication Date:

|Jun 13, 2026

Exposure to azithromycin and the effect of co-administration of rifampicin in patients with non-tuberculous mycobacterial disease.

|May 25, 2026

Activity of a three-phage combination against <i>Mycobacterium tuberculosis</i> in disease-relevant conditions.

|Mar 31, 2026

Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial.

Charles L Daley, Jakko van Ingen, James D Chalmers

|Jan 22, 2026

Clinical Characteristics and Management of Non-Tuberculous Mycobacterial Skin and Soft Tissue Infections: A Retrospective Cohort Study.

Wouter Peeters, Chang van Lier, Jakko van Ingen

|Dec 24, 2025

Survey on therapeutic drug monitoring practices for nontuberculous mycobacterial infections: an NTMnet/ESGMYC collaborative study.

Victor Næstholt Dahl, Nicole Maranchick, Jakko van Ingen

|Dec 10, 2025

Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?

Arthur Lemson, Esmee van der Pol, Jakko van Ingen

Pageof 11

Frequent Collaborators

11 joint publications

Wouter Hoefsloot

Mike Marvin Ruth

Ralf Stemkens

Dirk Wagner

Lian Pennings

Jelmer Raaijmakers

Jodie Anne Schildkraut

3 joint publications

Reinout van Crevel

3 joint publications

Won-Jung Koh

3 joint publications

Stefano Aliberti

Frequent Collaborators

11 joint publications

Wouter Hoefsloot

8 joint publications

Mike Marvin Ruth

6 joint publications

Ralf Stemkens

6 joint publications

Dirk Wagner